Jennifer Binning

Biochemist and Structural Biologist | Assistant Member at the Moffitt Cancer Center [she/her]

[Lyssiotis Lab @LyssiotisLab]

Absolutely spot-on advice for PhD program applications (coming from another Graduate Program Director).

I'll highlight maybe one of the less intuitive:
->Avoiding or hiding weaknesses<-
Tell us why. Life happens. Otherwise we are left guessing, and that distraction can derail an otherwise great discussion.

https://t.co/XgwYcpMmoJ

[Jennifer Binning @JenBinning]

Thrilled to see our manuscript highlighted by IPVS as their Paper of the Week! 🎉

Our team has been working hard to advance new approaches for targeting HPV-driven cancers, and it’s incredibly rewarding to see this work recognized by the HPV research community. Thanks to IPVS!

[IPVS - International Papillomavirus Society @IPVSociety]

Targeted therapies for #HPVrelated #cancers are greatly needed. The development of an E6-targeting #PROTAC degrade the #HPV viral oncogene and inhibits HPV+ tumor growth through tumor-intrinsic and immunomodulatory effects. ➡️ https://t.co/4AGTZcbRGB

@MoffittNews @CellPressNews

[IPVS - International Papillomavirus Society @IPVSociety]

Targeted therapies for #HPVrelated #cancers are greatly needed. The development of an E6-targeting #PROTAC degrade the #HPV viral oncogene and inhibits HPV+ tumor growth through tumor-intrinsic and immunomodulatory effects. ➡️ https://t.co/4AGTZcbRGB

@MoffittNews @CellPressNews

[Jennifer Binning @JenBinning]

I love the opportunity to talk about my love for science, research, and learning!

[Moffitt Cancer Center @MoffittNews]

From solving math puzzles in third grade to developing new therapies for HPV-related cancers, Jennifer Binning, PhD (@JenBinning) has always loved a challenge.

Today, she combines her passion for research with a drive to make a difference in oncology. At Moffitt, she leads collaborative efforts to better understand how cancer works and how to stop it.

Read more about her journey and the research shaping the future of cancer care: https://t.co/YkhMqSBRpo

[Moffitt Cancer Center @MoffittNews]

From solving math puzzles in third grade to developing new therapies for HPV-related cancers, Jennifer Binning, PhD (@JenBinning) has always loved a challenge.

Today, she combines her passion for research with a drive to make a difference in oncology. At Moffitt, she leads collaborative efforts to better understand how cancer works and how to stop it.

Read more about her journey and the research shaping the future of cancer care: https://t.co/YkhMqSBRpo

[Jennifer Binning @JenBinning]

@CancerBiol_PhD @vcluca1 @ElliotMedina31 Congratulations, Elliot!

[Rutter Lab @RutterLab]

Hello everyone! I am helping to organize a one-day symposium on fluorescent metabolite biosensors and their use in metabolism research. It will be May 12-13 and associated with the Cold Spring Harbor Laboratory “Mechanisms of Metabolic Signaling” Symposium. Our field needs to be able to visualize metabolism with spatial and temporal resolution and this symposium will explore what to do and how to do it, with experts in metabolism and biosensor development and use. Please join us! https://t.co/8QfiKTCeDs -JR

[Moffitt Cancer Center @MoffittNews]

A Moffitt patient made history as the first to receive a second CAR T therapy for ovarian cancer, a breakthrough made possible by cancer research.

After her initial treatment in June 2023, her care team is hopeful that this second infusion will cure her ovarian cancer once and for all.

This is the power of research to transform lives.

Read her full story: https://t.co/4hZmYfutrY
#MoffittImpact

[Ansu Satpathy @Satpathology]

More than 2/3 of new medicines are created by biotech and in-licensed by pharma, and nearly every innovative biotech comes from academia. That’s because it takes years and years of sustained and consistent focus and perseverance on a basic biological problem to lead to innovative drugs. This is not something that pharma can usually support. Youtube Jim Allison and checkpoint blockade.

Yes, we can improve efficiency, but IMHO the NIH should come up with creative solutions to expand the pipeline and participate in the upside of medicines that it helps create, rather than severely cutting infrastructure for a key industry and opportunity for US growth.

[Jennifer Binning @JenBinning]

@KarrethLab @NeelJasani @CR_AACR @LabDeNicola @KarenMannLab @LabSmalley @LabElsaFlores @ColoffLab Congratulations!!!

[Davide Ruggero @RuggeroDavide]

Amazing paper on specialized ribosomes and their roles in cancer immune response! Congrats @liamfaller and all team!

[Weitzman Lab @WeitzmanLab]

We are hiring an Assistant Professor in Cancer Pathobiology at CHOP/Penn. This is a great opportunity to join the fantastic Penn community. Please apply &amp; share. https://t.co/LqZ6UaJlm3

[Jennifer Binning @JenBinning]

Don’t miss this opportunity! Great science and an even better lab.

[Karreth Lab @KarrethLab]

We are still recruiting a postdoc #RNA #melanoma #glycoRNA. Please share. Details here:

Postdoctoral Fellow – RNA Modifications in Melanoma in Tampa, FL - Moffitt Cancer Center Careers https://t.co/5Geo5g1Kiz

[Vince Luca @vcluca1]

I am excited to share our @NatureComms paper describing the structure of #LAG3 bound to MHC-II. This project was carried out by @SuperMQQ et al at @MoffittResearch and provides new insights into the mechanism by which LAG3 suppresses T cell activation. https://t.co/8HiBfWeYV7

[Rapé Lab @RapeLab]

Huge shoutout to Chris Lima's lab @MSKCancerCenter @HHMINEWS for capturing basically the entire ubiquitylation cascade via cryo-EM!!! Congratulations to this creative tour-de-force that follows ubiquitin's path towards a substrate.

https://t.co/tMqLuAIGvR

[Jennifer Binning @JenBinning]

@GaryReuther_ @Garima_Pandey19 @AjHematology @MoffittNews Congrats @GaryReuther_ and @Garima_Pandey19!

[Henriette E Autzen @HenrietteAutzen]

Five days left to apply for the postdoc position in my group, and to become part of the amazing team I work with as depicted by PhD student @ciara_pugh

[Kyle L. Morris @kylelmorris]

We have an open position for a biocurator @EMDB_EMPIAR ! Raw data, maps, molecules - join our mission here at @emblebi to make these available to the community. #cryoem #StructuralBiology

[Leanna Smithberger @DrSmithberger]

The Moffitt research community hasn't stopped talking about the most recent #MIOTSymposium and the inspiring potential of this latest cohort of Innovators. Want to be part of our next cohort? Apply for our October 17-18, 2024 event at https://t.co/CUb867Uk5b @MoffittNews

[Jennifer Binning @JenBinning]

This year's Molecular Oncology retreat was filled with great science, networking, and a few laughs, especially for the science-themed skits!

[Eric Lau @EricLauLab]

Thanks to @ajaeger40, @KarrethLab, and @LabKissil, as well as the administrative staff for organizing today’s Molecular Oncology retreat! Happy to share the emotional and riveting faculty interpretive dance rendition of Central Dogma!